World Investment Advisors LLC Invests $752,000 in Colgate-Palmolive (NYSE:CL)

World Investment Advisors LLC acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,248 shares of the company's stock, valued at approximately $752,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Main Street Research LLC grew its position in shares of Colgate-Palmolive by 1.5% in the second quarter. Main Street Research LLC now owns 6,939 shares of the company's stock valued at $673,000 after purchasing an additional 100 shares in the last quarter. Advisor OS LLC boosted its stake in Colgate-Palmolive by 4.5% during the second quarter. Advisor OS LLC now owns 2,348 shares of the company's stock worth $228,000 after buying an additional 101 shares during the last quarter. BLB&B Advisors LLC grew its holdings in Colgate-Palmolive by 2.5% in the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company's stock valued at $421,000 after buying an additional 104 shares in the last quarter. D Orazio & Associates Inc. increased its position in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock worth $297,000 after purchasing an additional 108 shares during the last quarter. Finally, Fiducient Advisors LLC lifted its holdings in Colgate-Palmolive by 5.2% in the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company's stock valued at $232,000 after acquiring an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Up 0.6 %

NYSE:CL traded up $0.57 during midday trading on Tuesday, hitting $93.49. 5,606,532 shares of the company were exchanged, compared to its average volume of 4,387,074. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a fifty-two week low of $76.96 and a fifty-two week high of $109.30. The company has a market capitalization of $76.38 billion, a PE ratio of 26.63, a price-to-earnings-growth ratio of 3.31 and a beta of 0.43. The company has a fifty day simple moving average of $95.62 and a 200 day simple moving average of $98.70.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 57.31%.

Wall Street Analyst Weigh In

CL has been the topic of a number of research analyst reports. Piper Sandler assumed coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 target price on the stock. Stifel Nicolaus cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, October 28th. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Monday. Finally, JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.